Medicamen Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
For the full year, sales was INR 1,408.67 million compared to INR 1,154.45 million a year ago. Revenue was INR 1,433.3 million compared to INR 1,171.65 million a year ago. Net income was INR 148.44 million compared to INR 148.97 million a year ago. Basic earnings per share from continuing operations was INR 11.82 compared to INR 12.19 a year ago. Diluted earnings per share from continuing operations was INR 11.82 compared to INR 12.19 a year ago.